Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression

被引:74
|
作者
Mailloux, Adam W. [2 ]
Young, M. Rita I. [1 ,3 ,4 ]
机构
[1] Ralph H Johnson VA Med Ctr, Res Serv 151, Charleston, SC 29401 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA
[3] Med Univ S Carolina, Dept Otolaryngol, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
关键词
regulatory T cell; Treg; migration; trafficking; localization; chemokine; inflammation; cancer; immune suppression; TRANSCRIPTION FACTOR FOXP3; DRAINING LYMPH-NODES; BONE-MARROW; DENDRITIC CELLS; CHEMOKINE RECEPTOR; HEPATOCELLULAR-CARCINOMA; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; HUMAN THYMOCYTES; OVARIAN-CANCER;
D O I
10.1615/CritRevImmunol.v30.i5.30
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) have become a priority for many investigators in immunology due to their potent immunosuppressive and tolerogenic effects. While Treg activity is required for normal immune homeostasis, dysregulation of their numbers can induce autoimmunity or aid in the pathogenesis of disease. Therefore, great effort has been made to understand the mechanisms by which Tregs accumulate in different areas of the body. Like other lymphocytes, Tregs migrate in response to a network of chemotactic stimuli involving chemokines, chemokine receptors, integrins, and their corresponding ligands. However, many of these stimuli are exclusive to Tregs, inducing their migration while leaving conventional populations unaffected. It is these selective stimuli that result in increased ratios of Tregs among conventional effector populations, leading to changes in immune suppression and homeostasis. This review explores selective Treg trafficking during thymic Treg development, migration to secondary lymphoid tissues and emigration into the periphery during homeostatic conditions, inflammation, and the tumor microenvironment, placing emphasis on stimuli :hat selectively recruits Tregs to target locations.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 50 条
  • [21] Identification and characterization of novel mediators of tumor-induced T-cell dysfunction
    Markowitz, Geoffrey J.
    Philip, Mary
    Schietinger, Andrea
    Mittal, Vivek
    CANCER RESEARCH, 2017, 77
  • [22] Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression
    Whiteside, Theresa L.
    VACCINES, 2016, 4 (04)
  • [23] Ovarian Tumor-Induced T Cell Suppression Is Alleviated by Vascular Leukocyte Depletion
    Bak, S. Peter G.
    Hart, Kevin
    Berwin, Brent
    TRANSLATIONAL ONCOLOGY, 2009, 2 (04): : 291 - 299
  • [24] VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
    Terme, Magali
    Pernot, Simon
    Marcheteau, Elie
    Sandoval, Federico
    Benhamouda, Nadine
    Colussi, Orianne
    Dubreuil, Olivier
    Carpentier, Antoine F.
    Tartour, Eric
    Taieb, Julien
    CANCER RESEARCH, 2013, 73 (02) : 539 - 549
  • [25] Interleukin 12 Stimulates IFN-γ-Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance
    Cao, Xuefang
    Leonard, Karen
    Collins, Lynne I.
    Cai, Sheng F.
    Mayer, Joshua C.
    Payton, Jacqueline E.
    Walter, Michael J.
    Piwnica-Worms, David
    Schreiber, Robert D.
    Ley, Timothy J.
    CANCER RESEARCH, 2009, 69 (22) : 8700 - 8709
  • [26] MATCHING OF CHEMOTHERAPY TO MOUSE STRAIN AND LYMPHOID TUMOR TYPE TO PREVENT TUMOR-INDUCED SUPPRESSION OF SPECIFIC T-CELL AND B-CELL FUNCTIONS
    FAANES, RB
    MERLUZZI, VJ
    WILLIAMS, N
    TARNOWSKI, GS
    RALPH, P
    CANCER RESEARCH, 1979, 39 (11) : 4564 - 4574
  • [27] Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression
    Whiteside, Theresa L.
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : 81 - 89
  • [28] Improving cancer immunotherapy by targeting tumor-induced immune suppression
    Trina J. Stewart
    Mark J. Smyth
    Cancer and Metastasis Reviews, 2011, 30 : 125 - 140
  • [29] Improving cancer immunotherapy by targeting tumor-induced immune suppression
    Stewart, Trina J.
    Smyth, Mark J.
    CANCER AND METASTASIS REVIEWS, 2011, 30 (01) : 125 - 140
  • [30] THYMIC AND EXTRATHYMIC T-CELL DEVELOPMENT
    不详
    IMMUNOLOGY TODAY, 1992, 13 (11): : 449 - 449